|
|
| Discussions for ImClone Systems Incorporated | View all discussions |
|
| Icahn's track record | ||
| Only 1 message in discussion - | ||
From: bon...@gmail.com
Date: Mon, 4 Aug 2008 11:16:03 -0700 (PDT)
Local: Mon, Aug 4 2008 2:16 pm
Subject: Icahn's track record
Please shareholders, don't listen to this billionaire. Yes, it could
turn out that the IMCL pipeline is worth more later than it is now, but this bid has to weigh the possibility of failure, and it is a pretty nice premium. I won't hide that I'm a BMY shareholder, but really, with the recent failures of drugs sending ELN, BIIB, SGP, and others spiraling, does IMCL's pipeline deserve a huge premium? (and is 45% not huge?) I love IMCL and would really like to have it be part of BMY, but nothing is certain, and I think this bid reasonably values the pipeline. Yes, your upside of remaining independent could be higher in 5 years, but so could the downside. In the end, as with YHOO, it will be up to the investors. BMY has
Thoughts? You must Sign in before you can post messages.
To post a message you must first join this group.
Please update your nickname on the subscription settings page before posting.
You do not have the permission required to post.
| ||||||||||||||
| End of messages |
| « Newer discussion - breaking: Eli Lily bidding for imclone 70$ per share | imcl - Older discussion » |
| Google Home - Terms of Service - Privacy Policy |
©2009 Google